Presentations by Tim Sandle

Listed below are some of the presentations, at conferences or as webinars, delivered by Tim Sandle.

To contact Tim about a presentation, conference or webinar, contact Tim via email.

PRESENTATIONS

1. 'Bacterial Endotoxin Test: Introducing Methodology' to the Parenteral Society One Day Seminar on LAL Testing, 14th March 2002, Manchester
2. ‘Future Direction of Pyrogen Testing’ to PharMIG AGM, November 2002, Peterborough
3. ‘Monitoring – What, When and How Often?’ to Pharmaceutical Cleanrooms, Cambridge, 18th March 2003 
4. ‘Sterility Testing – A Practical Approach’, PharMIG Microbiological Methods Validation Conference, St. Albans, 4th June 2003 
5. ‘Risk Assessment in the Pharmaceutical Industry’, AUDITS 13, Brussels, 16th September 2003 
6. ‘Current Practices in Sterility Testing’, Institute of Validation Technology Microbiology Event of the Year’, December 2003, Dublin 
7. ‘Practical Approaches to Sterility Test Validation’, PharMIG Microbiological Methods Validation Conference, Dublin, 25th March 2004 
8. ‘Three Aspects of LAL Testing: Glucans, Depyropgenation and Water System Qualification’, PharMIG Endotoxin Course, Waltham Abbey, 3rd June 2004
9. ‘Microbiological Environmental Monitoring in an Isolator Used for Aseptic Filling or Sterility Testing’, AUDITS 15, Brussels, 21st September 2004
10. ‘Environmental Monitoring Risk Assessment’, Institute of Validation Technology Microbiology Event of the Year’, November 2004, Amsterdam
11. ‘Constructing a Viable Environmental Monitoring Programme Using a Risk Assessment Approach’, Pharmaceutical Cleanrooms 2005, 6th September 2005, Cambridge
12. ‘Hot Topics in Pharmaceutical Microbiology’, two interactive sessions, PharMIG Conference, 23rd November 2005
13. ‘NHS Pay Reform’, National Institute of Biological Standards and Control, South Mims, 18th January 2006
14. Hot Topics in Pharmaceutical Microbiology’, interactive session, PharMIG Irish Conference, Cork, 8th June, 2006
15. Distribution of Microbiological Data’, PharMIG Irish Conference, Cork, 7th June, 2006
16. NHS financial crisis and the Blood Service’, NHS Together, Cambridge, 4th March 2007
17. Managing a Microbiology Laboratory Training Programme’, presenter on laboratory training programmes, 29th March 2007, PharMIG Training Event, Derby
18. ‘Applying Failure Mode and Effects Analysis (FMEA) to a Sterility Testing Isolator: A Case Study’, PharMIG Risk Based Management in Pharmaceutical Microbiology, 27th June 2007
19. ‘Managing a Microbiology Laboratory Training Programme’, presenter on microbiology laboratory training programmes, 27th September 2007, PharMIG Training Event, Dublin
20. ‘Best Practices in Microbiological Quality Control and Documentation’, workshop presenter on good documentation practises, 16th October 2008, Pharmig event, Northampton
21. Best Practices in Microbiological Quality Control and Documentation’, workshop presenter on good quality documentation practises, 1st April 2009, Pharmig event, Cork, Republic of Ireland.
22. ‘Managing a Microbiology Laboratory Training Programme’, presenter on microbiology laboratory training programmes, 10th June 2009, PharMIG Training Event, Dublin
23. ‘How to justify doing less monitoring, sampling and testing, and still pass a regulatory inspection’, Pharmig Annual Conference, Nottingham. Session run twice on 18th and 19th November 2009.
24. ‘Contamination control and pharmaceutical microbiology’, two day course co-hosted with Dr Nigel Halls, run for Nobel Farama, Turkey, 5th & 6th January 2010
25. Best Practices in Microbiology Training, two sessions, Pharmig Annual Conference, Nottingham. Session run twice on 24th and 25th November 2010
26. Regulatory Developments: Key Points for Microbiology, Pharmig Annual Conference, Nottingham. Session run twice on 24th and 25th November 2010
27. Cleanrooms and Air Contamination, VIENNI TRAINING, Prune, India, 6th January 2011
28. ‘The Use of Risk Assessment in the Pharmaceutical Industry – the application if FMEA to a Sterility Testing Isolator: A Case Study’, presented at Pharmaceutical Microbiology Conference (SMi Group), Copthorne Tara Hotel, London, 17th January 2011
29. ‘Approaching Sterility Testing’, Hulst Pharma Test Expo, Cologne, Germany, 9th February 2011
30. 'Developments in Regulatory Requirements', ECA 4th Microbiology Conference, Prague, 4th May 2011
31. 'Environmental Monitoring: sterile / non-sterile', ECA 4th Microbiology Conference, Prague, Czech Republic, 5th May 2011
32. "How to Justify Doing Less Monitoring, Sampling and Testing and Still Pass a Regulatory Inspection", PDA's 6th Annual Global Conference on Pharmaceutical Microbiology, Bethesda, MD, USA, 18th October 2011
33. Regulatory Update for Microbiology in 2011, Pharmig Annual Conference, Nottingham. 16th November 2011.
34. 'A risk based approach to environmental monitoring frequencies', ECA 5th Microbiology Conference, Frankfurt, Germany, 10th May 2012
35. Regulatory Updates: 2012, Pharmig Irish Conference, Cork, Ireland, 14 June 2012
36. USP Chapter 1116: environmental monitoring changes, Pharmig Irish Conference, Cork, Ireland, 14 June 2012 
37. ‘Review of Cleanroom Microflora’, NHS Pharmaceutical Quality Assurance Service, Annual Symposium for Technical Services, 25th September 2012, The Ashford International Hotel, Kent, UK 
38. 'Fungal contamination of pharmaceutical products', Pharmaceutical and Healthcare Sciences Society (PHSS) Annual Conference, 11th October 2012, Winchester, UK 
39. USP Chapter 1116: trends in environmental monitoring, Pharmig Annual Conference, Chipping Norton, UK. 6th November 2012
40. Webinar 'Human Microbiome Project', Microbiology Network (with Tony Cundell and Scott Sutton), 5th March 2013.
41. 'Fungi in pharmaceutical manufacturing', European Compliance Academy Microbiology Conference, Copenhagen, Denmark, 25th April 2013
42. 'USP 1116 and its impact upon pharmaceutical microbiology', Pharmig webinar, 1st May 2013
43. 'The use of control strains for the quality control of culture media', American Pharmaceutical Review Webinar, 14th August 2013 (with Liz Kerrigan of ATCC)
44. 'Hospitals, Water Systems and Contamination, NHS QA Symposium, Chester, UK. 24th September, 2013
45. 'Rapid Microbiology Methods and Risk Assessment in the Pharmaceutical Industry', American Pharmaceutical Review Webinar, 16th October 2013 (with Jackie Horrige, BioVigilant)
46. 'The Human Microbiome Project and Implications for Pharmaceutical Microbiology', PDA 8th Microbiology Conference, Bethesda, MD, USA, 21st October 2013
47. 'Best Microbiological Practices for cleanroom gowns, gloves and masks', Pharmig Annual Conference, 21st November, 2013
48. 'Implications of fungal contamination of pharmaceutical products', Pharmig Annual Conference, 21st November, 2013 
49. Best practices in managing microbial excursions and managing out of specification events, webinar for European Pharmaceutical Review, 3rd December 2013 
50. Fungi and pharmaceutical manufacturing, webinar for Pharmig, 19th February 2014 
51. Fungal contamination of pharmaceuticals products, Making Pharmaceuticals, National Motorcycle Museum, Birmingham, 29th April, 2014 
52. Human Microbiome Project, European Compliance Academy, Prague, May 2014 
53. Essential Components for Implementation of a Robust Environmental Monitoring Program (with Anne Connors, Merck Millipore), American Pharmaceutical Review, webinar, 9th July 2014 
54. Contemporary issues in pharmaceutical microbiology, NHS QA Symposium, Kenilworth, UK, 17th September 2014 
55. Media Fill Trials for Aseptic Process Control in Sterile Pharmaceutical Manufacture, webinar for Cleanroom technology (with Colin Booth, ThermoFisher), 24th September 2014 
56. Key points for Cleanroom Disinfection, Gerpac 17th Conference, Presqu’ile de Giens, Hyères, France, 2nd October 2014. (DOI: 10.13140/2.1.5029.76) 
57. Constructing an environmental monitoring program, BioMonitoring Seminar, Environmental Monitoring & Risk Analysis in pharmaceutical Industry, Evoluon, NL-Eindhoven, Netherlands, 9th October 2014 
58. Risk assessment for environmental monitoring, BioMonitoring Seminar, Environmental Monitoring & Risk Analysis in pharmaceutical Industry, Evoluon, NL-Eindhoven, Netherlands, 9th October 2014 
59. An environmental monitoring workshop, BioMonitoring Seminar, Environmental Monitoring & Risk Analysis in pharmaceutical Industry, Evoluon, NL-Eindhoven, Netherlands, 9th October 2014 (with Dr. David Roesti). 
60. Cleanroom contamination and disinfection, Pharmig Cleanroom seminar, 28th October 2014, Birmingham, UK 
61. Implications of the human microbiome for cleanrooms, Pharmig Annual Conference - Key Note Speaker, Nottingham, UK, November 2014
62. Risk Based Environmental Monitoring & Lean Manufacturing, 25th February 2015, Novatek International, Webinar. 
63. Best practices for an environmental monitoring programme, Making Pharmaceuticals, National Motorcycle Museum, Birmingham, U.K. April 28, 2015 
64. Risk assessment and microbiological risks to pharmaceuticals, Making Pharmaceuticals, National Motorcycle Museum, Birmingham, U.K. April 28, 2015 
65. Webinar - Microbiological Risk of Personnel and Cleanrooms - 28th May 2015 
66. Webinar - Disinfection/Sanitisation Processes: cGMP for Cleaning and Disinfection, 25th June 2015, Pharmig - 25th June 2015 
67. The Problem with Spores in Aseptic Units, presented at 'Sporicides – As Part Of Your Transfer Process' - a Pharmig ./ NHS joint symposium, Birmingham, U.K. on 1st July 2015 
68. Sporicidal Products - a problem of definition and control, presented at 'Sporicides – As Part Of Your Transfer Process' - a Pharmig ./ NHS joint symposium, Birmingham, U.K. on 1st July 2015 
69. Environmental control and environmental monitoring, presented at King's College Hospital NHS Trust, London, U.K., on 24th July 2015 
70. Validation of an Agar Plate Active Microbial Air Sampler According to ISO 14698, Merck webinar, 16th September 2015 
71. The future of ISO 14698, Merck webinar, 16th September 2015 
72. Microbiology Laboratory Myths, 10th PDA Global Microbiology Conference, Bethesda, MD, USA, 19th October 2015 
73. Ask the experts panel, 10th PDA Global Microbiology Conference, Bethesda, MD, USA, 19th October 2015 
74. Disinfection Processes for Pharmaceuticals and Surface Sampling on Sanitized Surfaces, Merck webinar, broadcast in Europe and North America (2 sessions) on 22nd October 2015 
75. Bioburden control and objectionable organisms (with Andy Martin), Pharmig Microbiology Conference, Nottingham, U.K., 25th November 2015 
76. Environmental Monitoring Risk Assessment and the Lean Approach, Pharmig Microbiology Conference, Nottingham, U.K., 26th November 2015 
77. Best practices for aseptic operator practice and gowning, Pharmig Microbiology Conference, Nottingham, U.K., 26th November 2015 
78. ISO 14644 Revision to Parts 1 and 2 (2015 updates), Pharmig webinar, 4th February 2016 
79. Overview of environmental monitoring regulations, Pharmig Environmental Monitoring Course, The Oxfordshire Hotel, Oxford, 3rd March 2016 
80. Environmental monitoring incubation strategies, Pharmig Environmental Monitoring Course, The Oxfordshire Hotel, Oxford, 3rd March 2016 
81. Bacterial and fungal spores - aseptic processing risks, Pharmig & NHS Sporicidal Meeting, The Oxfordshire Hotel, Oxford, 4th March 2016 
82. Selection of disinfectants and sporicides, Pharmig & NHS Sporicidal Meeting, The Oxfordshire Hotel, Oxford, 4th March 2016 
83. Environmental monitoring trending for risk mediation and lean manufacturing, PDA Europe, 10th May 2016 - webinar 
84. Environmental monitoring and microflora - key points, ECA Pharmaceutical Microbiology Conference, Barcelona, 11th May 2016 
85. Investigating Sterility Test Failures, Joint Pharmaceutical Analysis Group, Royal Society for Chemistry, London, 12th May 2016 
86. Environmental monitoring incubation strategies, Pharmig Irish Conference, Fota Island Hotel, Cork, 18th May 2016 
87. Best practices in pharmaceutical gowning, at: PHSS Sterile Products Manufacture June 9, 2016, Hallmark Hotel Manchester Airpor 
88. Best practices for investigating sterility test failures, Pharmig webinar, 6th September 206 
89. Depyrogenation Studies, A3P, Lyon, 18th September 2016 
90. Best practices with microbiological culture media, Pharmig 24th Conference, Nottingham, UK, 17th November 2016 
91. Cleanroom contamination; the Problem Spores and the need for Sporicides, Pharmig conference, Wednesday 15th Feb 2017 - Nailcotte Hall Hotel, Berskwell, Warwickshire 
92. Introduction to cleanrooms, Thursday 16th Feb 2017- Nailcotte Hall Hotel, Berskwell, Warwickshire 
93. Current regulations for environmental monitoring, Wednesday 24th May 2017, Pharmig conference, Portmarnock Hotel & Golf Links, Co. Dublin, Ireland 
94. Selecting culture media for environmental monitoring, Wednesday 24th May 2017, Pharmig conference, Portmarnock Hotel & Golf Links, Co. Dublin, Ireland 
95. Approaching depyrogenation, Pharmig webinar, 10th August 2017
96. ‘Fungal Contamination in Pharmaceutical Products and Cleanroom Risk’, webinar for Pharmig, 4th October 201 
97. Environmental monitoring - limitations, incubating, and trending, 18th October 2017, Pharmig / Samples H conference: Hot Topics in Pharmaceutical Microbiology for the Adriatic Region, Otocec, Slovenia 
98. Training in cleanroom contamination, disinfection, and cleaning techniques, 18th October 2017, Pharmig / Samples H conference: Hot Topics in Pharmaceutical Microbiology for the Adriatic Region, Otocec, Slovenia 
99. How to manage sterility test issues and failure investigations, 18th October 2017, Pharmig / Samples H conference: Hot Topics in Pharmaceutical Microbiology for the Adriatic Region, Otocec, Slovenia 
100. Quantitative determination of endotoxin, Pharmig open discussion session, Pharmig Annual Conference, Oxfordshire, UK, 30th November 2017 
101. Risk Based Approach to Environmental Monitoring, webinar for Compliance Online, 19 December 201 
102. Sterility test failure investigations, webinar for Compliance Online, 23 Jan 2018 
103. Review of EU GMP Annex 1, webinar for Compliance Online, 15 March 201 
104. Introduction to disinfectants for GMP industries, Ecolab webinar, 3 April 2018 
105. Fungi and cleanroom contamination, webinar for Compliance Online, 26 April 2018 
106. Pharmig review of Annex 1, Pharmig webinar, 3 May 201 
107. Bacterial and fungal spore risks to pharmaceutical processing, Webinar, Online Compliance Panel, 23rd May 201 
108. Best practices in microbial culture media, Pharmig Irish Conference, Dublin, Ireland, 30th May 2018 
109. Insight into EU GMP Annex 1, Pharmig Irish Conference, Dublin, Ireland, 30th May 2018 
110. Introduction to FMEA: Risk assessment tool for pharmaceuticals, Pharmig risk assessment course, Dublin, Ireland, 31st May 2018 
111. Good Design Practices For Pharmaceutical Water Systems, webinar, Online Compliance, 28th June 2018
112. Developing a meaningful environmental monitoring programme, Pharmig Hot Topics Pharmaceutical Microbiology – India, 17^th July, Hilton Bangalore Embassy Golf Links, Bangalore
113. Developing a meaningful environmental monitoring programme, Pharmig Hot Topics Pharmaceutical Microbiology – India, 19^th July, Hyatt Hyderabad Hotel, Hyderabad
114. Introducing the human microbiome, Webinar, Online Compliance Panel, 25th July 2018
115. Cleanrooms and contamination control, Webinar, Online Compliance Panel, 30^th August 2018
116. Burkholderia cepacia complex: risks to non-pharmaceutical products, Webinar, Online Compliance, 20^th September 2018
117. Pharmaceutical microbiology: Current and future challenges, PDA Europe – Key Note Speaker, Berlin, 15^th October 2018
118. Global Best Practices for Cleaning and Disinfection of Cleanrooms and Disinfection Validation, Online Compliance Panel, 18^th October 2018
119. Cleaning Validation Top Challenges: What you need to know, Novatek International Webinar, 24^th October 2018
120. Pharmaceutical Water Systems: Microbiological Control, Pharmig Webinar, 24^th October 2018
121. Cleanrooms gown and personal control, 22^nd November 2018, Online Compliance Panel
122. Best practices in microbiological culture media, Pharmig Annual Conference, 28^th November 2018
123. Best practices in sterilisation by heat, UCL QP Training London, 5^th December 2018
124. Best practices for sterilisation by filtration, UCL QP Training London, 5^th December 2018
125. Sterility test best practices, UCL QP Training London, 5^th December 2018
126. Best practices for microbial identification, webinar, Compliance Online, 14^th December, 2018
127. Risk assessment case studies for environmental monitoring, Pharmig Environmental Monitoring Best Practices, Nailcotte Hotel, Birmingham, 13^th February 2019
128. Impact of the microbiome on environmental monitoring, Pharmig Environmental Monitoring Best Practices, Nailcotte Hotel, Birmingham, 13^th February 2019
129. Problem of bacterial and fungal spores in pharmaceutical facilities, Online Compliance Panel, 21^st February 2019
130. Out of Specification Investigations: A New Look at the Topic, 7^th March 2019, webinar for Online Compliance Panel
131. Applying FMEA risk assessment to a sterility testing isolator, 21^st March 2019, webinar for Online Compliance Panel
132. What to expect from the revised EU GMP Annex 1?., Pharmig Croatia Conference, 27^th March 2019, Zagreb
133. Operation of sterility test isolators and validation issues, Pharmig Croatia Conference, 27^th March 2109, Zagreb
134. Cleaning and disinfection of cleanrooms – why e-learning matters, Pharmig Croatia Conference, 27^th March 2019, Zagreb
135. What to expect from the revised EU GMP Annex 1?., Pharmig Slovenia Conference, 28^th March 2019, Ljubljana
136. Operation of sterility test isolators and validation issues, Pharmig Slovenia Conference, 28^th March 2019, Ljubljana
137. Cleaning and disinfection of cleanrooms – why e-learning matters, Slovenia Conference, 28^th March 2019, Ljubljana
138. Introducing Pharmig’s e-learning platform for cleaning and disinfection of cleanrooms, webinar for Pharmig, 18^th April 2019
139. How to justify doing less microbiological sampling and testing, and still pass a regulatory inspection, 25^th April 2019, Online Compliance Panel
140. Best practice in environmental monitoring, Assuring the quality of medicines III: aseptic products, Royal Society of Chemistry, London, 9th May 2019
141. Aseptic processing challenges panel, Assuring the quality of medicines III: aseptic products, Royal Society of Chemistry, London, 9th May 2019
142. Microbiological aspects of cleaning validation, Pharmig Irish Conference, Dublin, 15^th May 2019
143. Best practices in endotoxin testing open discussion, Pharmig Irish Conference, Dublin, 15^th May 2019 (run twice)
144. Three case studies relating to endotoxin contamination in water systems, Pharmig Pharmaceutical water systems, Dublin, 16^th May 2019
145. Practical Approaches to Sterility Test Validation: Overcoming difficult products, Online Compliance Panel webinar, 24^th May 2019
146. Cleanroom gowning and personnel control, Pharmig webinar, 12^th June 2019
147. Handling data integrity in the microbiology laboratory, Online Compliance Panel webinar, 20^th June 2019
148. Developing an environmental monitoring programme, Online Compliance Panel webinar, 11^th July 
149. Developing a contamination control study for pharmaceuticals and healthcare, 1^st August 2019, Online Compliance Panel webinar
150.  Fungal Contamination and Pharmaceutical Products Recall, 19^th September 2019, Online Compliance Panel webinar
151. Supplier Oversight and Quality Control for Patient Safety, Voices In Validation, 4^th October 2019
152. Risk assessment and environmental monitoring. At Pharmig’s Best Practices in Microbiological Environmental Monitoring, 15th October 2019 Radisson, Hyderabad, India
153. Risk assessment and environmental monitoring. At Pharmig’s Best Practices in Microbiological Environmental Monitoring, 16th October 2019, Hilton, Mumbai, India
154. Fungal contamination of pharmaceutical products, webinar compliance online, 19^th October 2019
155.  Environmental monitoring – best practices, Pharmig annual conference, 13^th November 2019, Nottingham  UK
156. New regulatory standards and updates, Pharmig annual conference, 14^th November 2019, Nottingham  UK
157. Human microbiome and its implications for cleanrooms, NHS QA and Technical Services Symposium, Bristol, UK, 27^th November, 2019 – Key note speaker
158. What to Expect From the New EU GMP Annex 1, Online Compliance Panel webinar, 9^th January 2020
159. Risk assessment of aging pharmaceutical facilities, Pharmig webinar, 6^th February 2020
160. The lean laboratory and a new approach for environmental monitoring, Online Compliance Panel, 13^th February 2020
161. The problem with bacterial and fungal spores for pharmaceutical cleanrooms, Assentpro webinar, 25^th February 2020
162. Annex 1 2020 revision – an overview, Voices In Validation, 12th March 2020
163. Three case studies relating to endotoxin contamination in water systems, Pharmig Control of Pharmaceutical Water Systems, Virtual Conference, 31^st March 2020
164. EU GMP and the implications for sterile products manufacture, RRSL webinar, 1^st April 2020